Samuel Whiting
CIK 1870373 · Chief Medical Officer · last filed 2025-01-06
Samuel Whiting is a Chief Medical Officer who has filed 9 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for TPST, was dated Jan 6, 2025. Across all open-market trades the lifetime net is +$18.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $12.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$12.1K
1
9
$18.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TPST | Chief Medical Officer | 9,573 | $1.26 | $12.1K | $18.1K | 9 | 2025-01-06 |
Recent Filings
9 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-06 | TPST | Grant (A) | — | $0 | EDGAR |
| 2024-07-03 | TPST | Buy (P) | +4,672 | $10.0K | EDGAR |
| 2024-01-05 | TPST | Grant (A) | — | $0 | EDGAR |
| 2023-10-13 | TPST | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | TPST | Grant (A) | — | $0 | EDGAR |
| 2022-06-22 | TPST | Grant (A) | — | $0 | EDGAR |
| 2022-01-10 | TPST | Buy (P) | +1,700 | $8.2K | EDGAR |
| 2022-01-06 | TPST | Grant (A) | — | $0 | EDGAR |
| 2021-06-30 | TPST | Grant (A) | +201 | $0 | EDGAR |